CVR: 38757504
Forward Pharma Operations ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. In 2024, the company reported revenue of DKK 99,127 and a net result of DKK -68,343,758 compared with DKK 1,043,207 the year before. Equity amounted to DKK 280,041,147.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 99 t. | -68.3 mio. | 349.4 mio. | 280 mio. | - | |
| 2023 | 547 t. | 1 mio. | 302.1 mio. | 279.1 mio. | - | |
| 2022 | 724 t. | -27 mio. | 305.1 mio. | 278.1 mio. | - | |
| 2021 | 622 t. | -9.5 mio. | 327.1 mio. | 305.1 mio. | - | |
| 2020 | 351 t. | -10.1 mio. | 337.2 mio. | 314.6 mio. | - | |
| 2019 | 327 t. | -7.5 mio. | 346.7 mio. | 324.7 mio. | - | |
| 2018 | 105 t. | -15.8 mio. | 364.4 mio. | 332.2 mio. | - |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.054 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of October 30, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Forward Pharma Operations ApS.
As of October 30, 2025, Jakob Mosegaard Larsen has stepped down as liquidator of Forward Pharma Operations ApS.
On October 30, 2025, Forward Pharma Operations ApS exited liquidation.
Forward Pharma Operations ApS was dissolved on October 30, 2025.
Forward Pharma Operations ApS has published its annual report for 2024. Revenue came to DKK 99,127, and the net result was DKK -68,343,758.
As of February 26, 2025, Jakob Mosegaard Larsen is registered as liquidator of Forward Pharma Operations ApS.
As of February 26, 2025, Claus Bo Søndergaard Svendsen has stepped down as adm. dir. of Forward Pharma Operations ApS.
On February 26, 2025, Forward Pharma Operations ApS entered liquidation.
Forward Pharma Operations ApS has published its annual report for 2023. Revenue came to DKK 546,952, and the net result was DKK 1,043,207.
Forward Pharma Operations ApS has published its annual report for 2022. Revenue came to DKK 724,020, and the net result was DKK -27,022,415.
As of June 8, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Forward Pharma Operations ApS.
As of June 8, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Forward Pharma Operations ApS.
Forward Pharma Operations ApS has published its annual report for 2021. Revenue came to DKK 621,559, and the net result was DKK -9,486,972.
Forward Pharma Operations ApS has published its annual report for 2020. Revenue came to DKK 351,024, and the net result was DKK -10,108,937.
Forward Pharma Operations ApS has published its annual report for 2019. Revenue came to DKK 326,709, and the net result was DKK -7,546,712.
Forward Pharma Operations ApS has published its annual report for 2018. Revenue came to DKK 105,339, and the net result was DKK -15,791,179.
Forward Pharma Operations ApS has published its interim report for the period June 30, 2017 – December 31, 2017.
As of June 30, 2017, EY Godkendt Revisionspartnerselskab has been appointed auditor of Forward Pharma Operations ApS.
As of June 30, 2017, Claus Bo Søndergaard Svendsen is registered as adm. dir. of Forward Pharma Operations ApS.
Forward Pharma Operations ApS was founded on June 30, 2017.
Companies in the same industry and area
CVR 26392861
CVR 41366044
CVR 32971024
CVR 42666084
CVR 27701396
companydata.dk